Table 5.
Self-reported history of medications given for treating CC
| South Korea | |||||
|---|---|---|---|---|---|
| Medication Usage | How well did the medication treat your chronic cough? (%) | ||||
| Medication | (N = 101) | Not at all | A little bit | Somewhat | A great deal |
| None | 14.9% | – | – | – | – |
| Anti-tussives (such as common cold medicine) | 60.4% | 11.5% | 45.9% | 34.4% | 8.2% |
| Anti-epileptics (such as gabapentin) | 2.0% | 0.0% | 100.0% | 0.0% | 0.0% |
| Proton pump inhibitors | 14.9% | 0.0% | 46.7% | 46.7% | 6.7% |
| H2 blockers | 1.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Nasal Steroids | 5.9% | 16.7% | 33.3% | 50.0% | 0.0% |
| Inhaled steroids | 2.0% | 0.0% | 0.0% | 50.0% | 50.0% |
| Oral steroids | 2.0% | 0.0% | 50.0% | 0.0% | 50.0% |
| Beta-agonists | 3.0% | 0.0% | 66.7% | 33.3% | 0.0% |
| 1st-generation antihistamines | 17.8% | 5.6% | 50.0% | 38.9% | 5.6% |
| 2nd-generation antihistamines | 13.9% | 0.0% | 35.7% | 50.0% | 14.3% |
| Cough drops | 16.8% | 23.5% | 58.8% | 11.8% | 5.9% |
| Antibiotics | 18.8% | 21.1% | 31.6% | 31.6% | 15.8% |
| ICS-LABA | 6.9% | 0.0% | 42.9% | 42.9% | 14.3% |
| Prescribed Traditional Oriental Medicine | 10.9% | 0.0% | 45.5% | 54.5% | 0.0% |
| Traditional Oriental Medicine bought over the counter | 5.9% | 33.3% | 16.7% | 50.0% | 0.0% |
| Others | 4.0% | 50.0% | 50.0% | 0.0% | 0.0% |
| Ever taken codeine or hydrocodone-containing products for ≥ 1 month | 11.9% | Duration of regular use (months) | |||
| Mean | SD | ||||
| 9.25 | 8.11 | ||||
| Taiwan | |||||
|---|---|---|---|---|---|
| Medication usage | How well did the medication treat your chronic cough? (%) | ||||
| Medication | (N = 259) | Not at all | A little bit | Somewhat | A great deal |
| None | 19.3% | – | – | – | – |
| Anti-tussives | 50.2% | 16.9% | 60.8% | 20.8% | 1.5% |
| Anti-epileptics | 1.9% | 40.0% | 40.0% | 20.0% | 0.0% |
| Proton pump inhibitors | 11.2% | 10.3% | 51.7% | 31.0% | 6.9% |
| H2 blockers | 5.8% | 13.3% | 53.3% | 26.7% | 6.7% |
| Nasal Steroids | 25.9% | 10.4% | 64.2% | 20.9% | 4.5% |
| Inhaled steroids | 9.7% | 12.0% | 44.0% | 36.0% | 8.0% |
| Oral steroids | 5.8% | 0.0% | 60.0% | 20.0% | 20.0% |
| Beta-agonists | 13.5% | 11.4% | 42.9% | 34.3% | 11.4% |
| 1st-generation antihistamines | 13.1% | 5.9% | 64.7% | 29.4% | 0.0% |
| 2nd-generation antihistamines | 11.6% | 13.3% | 50.0% | 33.3% | 3.3% |
| Cough drops | 25.5% | 25.8% | 66.7% | 7.6% | 0.0% |
| Antibiotics | 12.4% | 15.6% | 50.0% | 28.1% | 6.3% |
| ICS-LABA | 8.9% | 4.3% | 39.1% | 47.8% | 8.7% |
| Prescribed Traditional Oriental Medicine | 21.6% | 16.1% | 58.9% | 19.6% | 5.4% |
| Traditional Oriental Medicine bought over the counter | 22.8% | 23.7% | 57.6% | 16.9% | 1.7% |
| Others | 2.3% | 0.0% | 50.0% | 50.0% | 0.0% |
| Ever taken codeine or hydrocodone-containing products for ≥ 1 month | 28.2% | Duration of regular use (months) | |||
| Mean | SD | ||||
| 18.68 | 45.65 | ||||
ICS-LABA inhaled corticosteroid and long-acting β2-agonist